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1. Introduction
Baculoviruses are arthropod‐specific, enveloped viruses with circular, supercoiled double‐
stranded DNA genomes [1]. They infect Lepidoptera (butterflies and moths), Hymenoptera
(sawflies) and Diptera (mosquitoes) [2]. While many viruses are studied because of their
damaging effects, the study of baculoviruses was stimulated by their potential utility to control
insect pests [3]. Later, the utility of baculovirus as gene expression vectors was evidenced and
a new research area emerged [4]. A major step forward was the development of bacmid
technology [5] (the construction of bacterial artificial chromosomes containing the genome of
the baculovirus) which allows the manipulation of the baculovirus genome in bacteria. With
this technology, foreign genes can be introduced into the bacmid by site‐ directed recombina‐
tion or by transposition. Baculoviruses have been used to explore fundamental questions in
molecular biology such as the nature of programmed cell‐death [6]. Moreover, the ability of
baculoviruses to transduce mammalian cells led to the consideration of their use as gene
therapy and vaccine vectors. Strategies for genetic engineering of baculoviruses have been
developed to meet the requirements of new application areas, and the establishment of new
genetic modification systems is still necessary when an unexplored experimental system is to
be addressed. The aim of this chapter is to detail the areas of application of the baculovirus in
basic molecular biology and applied biotechnology and the strategies used to generate
genetically modified baculoviruses according to each area of study.
1.1. Molecular biology of baculoviruses
Baculovirus genomes consist of a circular, double‐stranded DNA molecule with a size ranging
from 80 to over 180 kbp and encoding 90 to 180 genes.
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The name “baculovirus” is derived from the latin “baculum” (stick), denoting the rod‐shaped
nucleocapsids that are 230– 385 nm in length and 40–60 nm in diameter [1]. The virions are
enveloped and present two phenotypes: occluded virions (OVs) and budded virions (BVs).
These two types of virions differ in the origin and composition of their envelopes and their
functions in the virus life cycle. In both, the genome is complexed with multiple copies of a
small basic protein (p 6.9) which neutralizes the negative charge of the DNA and this structure
is protected by other proteins forming the nucleocapsid. The OVs are enclosed in a paracrys‐
talline matrix forming occlusion bodies (OBs), which are orally infectious. Their morphology
was initially used to define two major groups or genera of the Baculoviridae: the Nucleopo‐
lyhedrovirus (NPVs) and the Granulovirus (GVs). NPV OBs, called polyhedra, are about 0.6–
2 μm in size and their major occlusion protein is called polyhedrin. GV OBs, also known as
granules or capsules, are oval‐shaped with diameters in the range of 0.2–0.4 μm (Figure 1).
OBs are highly stable and can resist most normal environmental conditions thereby allowing
virions to remain infectious for very long periods of time.
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Figure 1. On the basis of the OB morphology, baculovirus were originally divided in two major groups: the Nucleopo‐
lyhedrovirus (NPVs) and the Granulovirus (GVs). NPVs occlusion bodies are called polyhedra and their major occlusion
protein is called polyhedrin and GV occlusion bodies and granules or capsules for GVs.
Based on the fusion protein present in the BVs NPVs have been further classified into two
groups: type I NPVs contain GP64, a low‐pH‐dependent membrane fusion protein required
for virus entry and cell‐to‐cell transmission [7,8,9,10], BVs of group II NPVs and GVs lack a
homolog of GP64, and membrane fusion during viral entry is triggered by F protein [11,12]. It
was found that the entry of baculoviruses in mammalian cells is mediated by GP64. In contrast,
baculoviruses with F protein cannot transduce these cells [13].
The natural cycle of infection by AcMNPV in insect larvae is summarized in Figure 2. Cater-
pillars ingest polyhedra that contaminate their food. The polyhedrin matrix is dissolved in the
alkaline environment of the larvae midgut releasing ODVs (occlusion derived virions). These
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virions enter midgut cells after fusion with membrane epithelial cells. The virions are uncoated
and enter the nucleus where viral genes are expressed.
The gene transcription of baculovirus has been divided in sequential phases: immediate early,
delayed early, late and very late. Immediate early genes are recognized by host transcription
factors and viral proteins are not necessary at this stage. Transcription of delayed early genes
requires activation by products of immediate early genes. The delayed early phase is followed
by the synthesis of DNA and the late gene products of the virus [14]. There is a close relation‐
ship between the DNA replication and the switch to late gene transcription, and it is believed
that these events are physically connected. In the late phase, that occurs following the initiation
of viral DNA replication, nucleocapsid structural proteins are synthesized, including glyco‐
protein GP64 playing a crucial role in the horizontal infection by BV [15]. During the very late
phase the production of infectious BV is greatly reduced. Nucleocapsids interact with nuclear
membranes and eventually become enveloped usually in groups of a few particles. Envelop‐
ment of the nucleocapsids appears to be an essential primary step in the process of occlusion
of nucleocapsids by the very late protein‐polyhedrin. The occlusion continues until eventually
the nucleus becomes filled with occlusion bodies. As occlusion proceeds, fibrillar structures
begin to accumulate in the nucleus (sometimes also in the cytoplasm). These structures are
composed mostly of a single polypeptide named p10, which is a very late protein [16]
The function of fibrillar structures is not clear but they may play a role in the controlled cellular
disintegration in caterpillars [17,18]. In the terminal stages of infection two viral proteins,
chitinase and cathepsin, act together to facilitate host cuticle breakdown [19]. After death the
caterpillar liquefies and releases polyhedra which can infect other insects. At the end of the
infection, OBs may account for over 30% of the dry weight of the larvae [20].
2. Baculovirus expression vectors
2.1. Introduction
The high levels of expression of the very late genes has been exploited to design the first vectors
for foreign gene expression based on baculoviruses. They are especially suitable regarding
safety (not harmful to non‐target organisms) and easy containment in the laboratory. Baculo‐
virus vectors are used to infect insect cells or larvae where high levels of recombinant proteins
are produced; the eukaryotic environment provides appropriate post-translational modifica‐
tions in comparison with prokaryotic expression systems. Insect cells to be used in the
baculovirus expression system are derived from lepidopteran insects and are relatively easy
to grow. No control of oxygen atmosphere is required. Moreover, insect cells can be adapted
to serum‐free media and production of recombinant protein can be scaled up to pilot plant or
larger bioreactors [21, 22]. The lepidopteran insect cells used are also normally free of human
pathogens. Thereby, the proteins produced in the baculovirus virus expression system can be
used for functional studies, vaccine preparations or diagnostics.
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Figure 2. Per os infection of baculoviruses. A cross sectional representation of the anatomy of an insect larva is depict‐
ed. A baculovirus occlusion body (OB) is ingested in contaminated food. OBs pass through the foregut and enter the
midgut where they dissolve in the alkaline midgut lumen and release occlusion derived viruses (ODVs).
A baculovirus expression vector (BEV) is a recombinant baculovirus that has been genetically
modified to lead the expression of a foreign gene. BEVs are viable in insect cell culture and
sometimes in larvae, depending on the baculovirus genes deleted in the process of the
recombinant virus generation. In BEVs, the foreign gene coding sequence is usually placed
under the transcriptional control of a viral promoter. For this reason usually viral factors are
required for the transcription of the foreign gene.
The most commonly used process for cloning recombinant baculovirus is briefly summarized
in Figure 3. Baculovirus genomic DNA and a transfer plasmid are cotransfected into an insect
cell culture. Double homologous recombination between viral DNA and transfer plasmid
causes the allelic replacement that incorporates the recombinant gene in the baculovirus
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genome. Clonal purification requires several plaque passages. After this, viral stocks can be
produced and amplified for recombinant protein production [31]. Insect cells are used for
purification of many proteins, including therapeutic and vaccine peptides. Larvae are used to
reduce production costs, or when recombinant baculovirus are to be tested as bioinsecticides.
Finally, baculovirus can be used for transduction of mammalian cells, for production of
therapeutic proteins, or to transduce organisms for gene therapy or vaccination.
Transfer plasmid containig 
          gene of interest
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Cotransfection into 
insect cell line
Lysis plaque formation
Virus plaque isolation and 
amplification
polyhedrin
recombinant protein purification Larvae infection transduction of mammalian cells
Transduced organism
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Gene therapy and cell response mediated immunity
 
Figure 3. General process for baculovirus cloning. Genomic DNA and a transfer plasmid are cotransfected into an in‐
sect cell culture. Recombinant virus propagates causing lysis plaques. Virus is isolated from lysis plaques and amplified.
Virus can be used for recombinant protein production in insect cells or larvae. Furthermore, baculovirus can be used
for transduction of mammalian cells or whole animals.
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2.2. Historical perspective
The major component of the polyhedrovirus OB is polyhedrin. This polypeptide comprises
about 25% of total cell protein in the late phase of baculovirus infection [23]. This was the main
property of baculovirus that led to their consideration as expression vectors. In the first studies
of baculovirus, AcMNPV polyhedrin gene was located and cloned. Then, a plasmid containing
the sequences of the polyhedrin gene (polh) and its flanking regions was constructed and
subsequently the polyhedrin open reading frame (ORF) was replaced with the reporter gene
β‐galactosidase [24]. This is the simplest version of a transfer plasmid, which contains the
strong polh promoter and upstream and downstream flanking sequences, but lacks the
polyhedrin ORF which is usually replaced with the coding sequence of a foreign gene of
interest. Transfer plasmid and viral DNA are cotransfected into cultured insect cells, where
allelic replacement of polyhedrin can occur via homologous recombination involving the
flanking viral sequences present in both DNAs.
This strategy was devised because the baculovirus genome is large [25]; and in vitro ligation
of foreign DNA fragments with restriction enzyme‐digested viral DNA has been successful
only in few cases [26, 27]. Other strategies that have been explored include enzymatic recom‐
bination in vitro [28] and homologous recombination in yeast followed by selection [29].
Although these methods are ingenious, neither has become part of the mainstream baculovirus
technology.
Allelic replacement is a consequence of double homologous recombination between viral DNA
and transfer plasmid, and occurs at a frequency of only about 1% [30]. Thus, the viral progeny
is a mixture of recombinant and wild type virus, which needs to be resolved in plaque assays.
The recombinant progeny is occlusion negative (occ‐) and produces polyhedrin‐ negative
plaques (cell plaques with no polyhedral OBs), whereas wild‐type progeny produces polyhe‐
drin‐positive plaques (occ+). Clonal purification requires several plaque passages. After this,
viral stocks can be produced and amplified to infect cell cultures for recombinant protein
production.
2.3. Strategies to simplify the isolation of recombinant baculoviruses
As mentioned before, following the strategy described above, the proportion of the progeny
virus population derived from the cotransfection experiment is less than 1% [31]. Plaque
purification of recombinant clones requires a tedious search for occ‐ plaques. Good quality
microscope and experienced eye are necessary, and few recombinant viruses can be screened
simultaneously because of the number of titrations required. To circumvent these problems,
several modifications in the parental viral genome were carried out in order to simplify the
isolation of recombinant baculoviruses, with the aim of reducing the parental virus yields in
the progeny of the co‐transfected insect cells.
One of the most successful strategies is the use of a linearized parental genome (in principle,
no virus can be recovered) instead of the circular viral DNA (fully infectious). The addition of
a unique naturally infrequent restriction site in the baculoviral genome allows the digestion
with the adequate restriction enzyme and digested parental DNA is cotransfected with transfer
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vector [32]. As linearized parental DNA has a reduced infectivity compared with its circular
counterpart, frequencies of recombinant progeny rise to about 30%. The baculoviral genome
can also be modified to contain restriction sites on both sides of a cassette containing a reporter
gene coding sequence (such as β‐galactosidase) under the control of a baculoviral promoter,
so that double digestion with this enzyme removes the reporter gene cassette. The presence of
two restriction sites reduces the frequency of undigested circular DNA genome. Moreover, if
undigested or single digested‐repaired parental DNA produces progeny, those few parental
plaques stain blue in the presence of X‐gal and can be easily discarded. This strategy was
exploited in the AcMNPV BEV system. In this virus, the genome was modified to contain
Bsu36I sites on both sides of the β‐galactosidase sequences, so that digestion with this enzyme
removed the gene and also part of a virus gene (ORF 1629) that encodes a structural protein
[33]. By removing part of the essential ORF 1629 gene, the virus is unable to form infectious
particles efficiently even if the double digested linear DNA is repaired and recircularized in
insect cells. In contrast, a process of homologous recombination repairs the deletion of ORF
1629 while simultaneously inserting the foreign gene in place of β‐galactosidase. Several
commercial systems make use of the repair of the deletion in ORF 1629. Among them, Bac‐to‐
Bac® (Invitrogen) and flashBacTM (Oxford Expression Technologies) quickly gained popu‐
larity in the scientific community.
2.4. Bacmid technology
A major step forward in the technology of baculovirus genetic engineering has been the
development of baculovirus genomes capable of replicating in a bacterial host as bacterial
artificial chromosomes (Figure 4). These recombinant baculoviruses are called bacmids, and
they have been modified to contain classical bacterial artificial chromosomes replicons and
selection markers for selection in bacteria. BAC vectors contain a fragment of E. coli fertility
factor (F‐ factor) replicon (miniF) and are maintained as circular supercoiled extrachromosomal
single copy plasmid in the bacterial host [57, 58]. BACs can accept inserts up to 300 Kb in length.
The principal advantage BACs have over other high insert capacity vectors like yeast artificial
chromosomes (YAC) and mammalian artificial chromosomes is stability of insert propagation
over multiple generations.
Once transferred into the bacterial host, the baculovirus genome can be manipulated easily
through site‐specific recombination, Rec‐A mediated homologous recombination or transpo‐
sition. Once the recombinant bacmid is generated and the presence of transgene and the
absence of the parental bacmid in the bacterial colonies are verified, e.g., by PCR, the DNA
from those colonies is purified and used to transfect susceptible insect cells. As was mentioned
above, naked genomic DNA from baculovirus can efficiently establish infection when it
reaches the cell nuclei. BV particles can be recovered from culture supernatant and used as
inoculum to produce high titer stocks.
Various commercial transfer vectors are available and compatible with bacmid systems to
allow expression of one or two proteins (e.g., pFastBac1TM and pFastBacDualTM from
InvitrogenTM). Some are designed to add tags and signal peptide sequences fused to the
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protein of interest in order to facilitate their purification. In addition, transfer vectors that are
compatible with GatewayTM and TOPO® cloning technologies have been developed.
A problem frequently found when working with BAC systems is the presence of parental
bacmid background even in the same colony where the recombinant bacmid is found, despite
the antibiotic‐based selection and blue‐white screening. This then requires a new transforma‐
tion of bacterial cells with mixed DNA and the screening of newly replated colonies. To avoid
this requirement, a negative‐selection system has been developed that makes use of the sacB
marker [59]. When the transposon is not integrated in the bacmid genome, the bacterial cell
will be killed in presence of sucrose due to the expression of sacB gene, which encodes an
enzyme that metabolizes sucrose to a toxic compound.
The first bacmid developed contained the AcMNPV genome. Later, bacmid systems were
developed for Bombyx mori NPV, Helicoverpa armigera single‐nucleocapsid nucleopolyhedro‐
virus (HearSNPV) [61] and Cydia pomonella granulovirus (CpGV) [60] (the first report of a
granulovirus bacmid).
Later, bacmid technology was exploited to develop a system that allows the generation of
recombinant baculoviruses with negligible background. This system relies on homologous
recombination in insect cells between a transfer vector containing a gene to be expressed and
a replication‐deficient AcMNPV bacmid. The deficiency of AcMNPV is due to a deletion in
the essential gene orf1629, and homologous recombination between bacmid DNA and transfer
vector (containing orf1629) repairs this deleted gene [62, 63, 64]. Therefore, only recombinant
virus can replicate and no further selection is required, facilitating the rapid production of
multiple recombinant viruses on automated platforms in a one‐step procedure. Several
commercial vectors (flashbackTM, Oxford Expression Technologies Ltd., BacMagicTM
(Merck), BaculoOneTM (PAA), etc.) follows this principle. All these systems claim that no
plaque purification of baculovirus is required, although it is recommended (there is a possi‐
bility that defective genomes can be replicated when a replication competent viral genome
resides in the same cell). Later, bacmids using this selection system were improved for protein
expression, carrying additional deletions in cathepsin (v‐cath) and p10 gene [65].
2.5. Improving protein quality and quantity in baculovirus expression systems
2.5.1. Introduction
The proteins to be expressed using recombinant baculovirus and insect cells are commonly of
mammalian origin and, as it happens in other expression systems, the expression levels and
the conformation and posttranslational modifications vary among individual proteins. The
principal purpose of a protein expression system is not only the production of large quantities
of recombinant protein, but also the production of a recombinant protein that resembles the
native protein. One of the most difficult challenges in expression systems is the expression of
transmembrane proteins. The correct expression of complex transmembrane proteins that
cross the membrane several times is even more difficult. In order to improve the quality in the
routing, the post-translational modifications and the stability of recombinant proteins, several
modifications have been carried out that address these limitations of baculovirus expression
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system. It is important to notice, however, that the protein is produced in the context of a viral
infection. Since certain protein processing pathways are compromised by baculovirus
infection, the capacity of host cells to correctly route, fold and modify the recombinant protein
is affected. This intrinsic limitation must be recognized and baculovirus expression system
must be regarded as a transient expression system.
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Figure 4. Baculovirus expression vectors over time. Various methods exist to generate recombinant baculoviruses ex‐
pressing a foreign gene (gene X). Historically, recombinant baculoviruses were generated through homologous re‐
combination (1). Subsequently, linearized vectors were developed to increase the percentage of recombinants (2).
Bacmid technology allowed the maintenance of defective baculoviruses as bacterial artificial chromosomes. Homolo‐
gous recombination with transfer vector in cells repairs the essential gene (3). Bacmid technology also allowed the
generation of recombinant baculovirus by in vitro transposition (4).
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2.5.2. Heterologous DNA properties and codon usage
Although the promoter elements that control the transcription of the heterologous gene are
derived from baculovirus, it is important to consider the effect of introducing heterologous or
artificial 5´ and 3´untranslated regions (UTR). The 5´UTRs of baculovirus are short AT‐rich
sequences. Therefore, the introduction of GC‐rich sequences upstream of the ORF may have
a negative effect on the heterologous gene transcriptional levels. The choice of 3´UTR,
including polyA sequences may also determine the heterologous gene expression levels. As
expected, p10 polyA signals are more efficient than the widely used SV40 terminator [66].
There are no in‐depth studies comparing the influence of codon usage on translation levels in
baculovirus expression systems. However, no strong bias in alternative codon frequency has
been observed in baculovirus coding sequences, suggesting that the codon optimization is
unlikely to improve significantly the translation levels [67].
2.5.3. Deletion of baculovirus genes to prevent proteolytic cleavage
Chitinase, the product of the gene chiA, is an enzyme that breaks down the chitin exoskeleton
of the insect host, together with cathepsin (V‐CATH, encoded by v‐cath) at the end of the
infection, ensuring the dispersal of the viral occlusion bodies [68]. As those genes have a
specific function in the context of the infection in the insect, they are not required for the
propagation of the virus in cultured insect cells. Chitinase is produced at high levels and stored
in the endoplasmic reticulum, and it may interfere in the secretory apparatus of the host cell.
On the other hand, cathepsin is a protease that is made as an inactive precursor (PRO‐V‐
CATH). PRO‐V‐CATH can be activated when preparing protein samples for SDS‐PAGE,
leading to the degradation of the recombinant protein. Bacmids were developed with deletions
in the genes chiA and v‐ cath, resulting in higher levels of secreted protein [69, 70].
2.5.4. Secretion of proteins
Many secretory pathway proteins have N‐terminal signal peptides that direct the protein
correctly through the ER and the Golgi system and ultimately to the surface of the cell. If the
signal peptide is not adequately recognized, the protein may be not targeted to the cell surface,
and the misfolded protein is also prone to degradation as it may be recognized by quality
control systems [71].
Native signal peptides of mammalian proteins may be replaced by signal peptides derived
from insect proteins such as the signal peptide of honey bee melittin [72] or derived from
baculovirus proteins, such as the GP64 signal peptide. Although the introduction of insect
signal peptides normally targets the protein to cell surface, it does not always lead to a correct
folding of the protein.
2.5.5. Glycosylation of proteins in the baculovirus‐insect cell system
Glycosylation is a common covalent chemical modification that can affect many protein
properties, including intracellular trafficking, biological function, immunological properties
and biochemical stability. One of the most advantageous features of the baculovirus‐insect cell
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system is that it can produce glycosylated proteins. However, the protein glycosylation
pathways of lepidopteran cells differ from those of higher eukaryotes [73]. N‐glycosylation
begins in insect cells with the transfer of the oligosaccharide Glc3Man3GlcNAc2 (where Glc,
Man and GlcNAc refer to glucose, mannose and N‐acetylglucosamine, respectively) from a
lipid complex to an asparagine residue in the polypeptide chain in the ER lumen. As the protein
passes through the ER and Golgi system, enzymes trim and add different sugar moieties to
this N‐linked glycan. In this step is where insect and mammalian cells start to vary. This results
in glycoproteins with simple oligomannose sugar chains in insects, while in mammals complex
sugar groups with terminal sialic acids are added.
Differences in glycosylation patterns may affect the folding and targeting of recombinant
glycoproteins and their immunological properties. Moreover, differences in glycosylation may
even lead to protein degradation [74].
To overcome the limitations of the baculovirus insect‐cell system in glycosylation, a series of
transgenic cell lines derived from lepidopteran Sf9 and High Five cells expressing genes for
the enzymes required to produce the complex mammalian glycosylation patterns were
developed [75, 76]. Genes incorporated include bovine β‐1,4‐galactosyl transferase and rat α‐
2,6 sialyltransferase. The introduction of these enzyme resulted in the incorporation of
galactosyl and sialyl residues in the produced proteins.
2.5.6. Expression of cytosolic and ER processing enzymes
Proteins to be secreted are translated in the cytosol and can translocate across the ER membrane
either by a cotraslational or post‐traslational mechanism. Transport in mammalian cells is
primarily cotraslational, and in yeast both post‐traslational and cotraslational mechanisms are
used. In insect cells, the predominant mechanism is still not known. In mammalian cells, the
cytosolic chaperone hsp70 is believed to contribute to the traslocation of proteins by interacting
with nascent polypeptides and preventing their aggregation. Coexpression of immunoglobu‐
lin G (IgG) and human hsp70 resulted in higher levels of soluble IgG precursor. As a conse‐
quence, mature IgG secreted levels increased [77].
In the ER chaperones also assist the folding of polypeptides by preventing improper aggre‐
gations and conformations. In mammalian cells, immunoglobulin heavy chain binding protein
(BiP) is an ER chaperone that interacts with several polypeptides destined for secretion and
may be involved in the translocation or proteins across the ER membrane. When recombinant
BiP was coexpressed in insect cells with IgG the soluble and secreted IgG levels were increased
[78]. Other additional chaperones, such as calnexin and calreticulin, can also assist folding and
assembly of membrane proteins in BEVs. Catalytic enzymes in the ER also collaborate by
accelerating the folding. Disulfide bond formation occurs in the oxidizing ER compartment,
with the catalytic action of protein disulfide isomerase (PDI). Studies demonstrated that
overexpression of PDI increases the folding and secretion of IgG in insect cells [79]. It has been
observed that co‐expression of foldases appears to work more efficiently when the corre‐
sponding genes are provided by the baculovirus vector than those integrated in the genome
of transgenic cell lines. This observation may be related to the phenomenon of host genome
transcriptional shut down known to occur during baculovirus infection.
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2.6. Improving baculovirus genome stability
A major drawback that limits the application of baculovirus for large‐scale production is the
accumulation of defective interfering (DI) particles upon serial viral cell culture passages. DI
particles are not able to propagate autonomously due to deletion of large portions of their
genomic DNA, but can co‐propagate in the presence of viable virus [80]. Since deletion often
includes the inserted foreign gene of interest, when DI particles proportion increases, re‐
combinant protein expression levels decreases. The accumulation of DI particles can be
reduced by the practice of infecting at low multiplicities of infection (MOI).
Genetic engineering strategies have been developed to prevent the accumulation of DI
particles. In Spodoptera exigua MNPV (SeMNPV), it has been observed that DI particles are
enriched in a non‐hr ori fragment. Removal of this non‐hr ori from the genome of the baculovirus
prevented the formation of DI particles up to 20 cell culture passages [81]. Removal of an
AcMNPV non‐ hr ori had the same effects on genomic stability. It was also observed that when
a large foreign fragment of DNA is cloned in baculovirus DNA genome in which no selection
pressure exists, the addition of an hr (which functions as origin of replication) may prevent the
loss of the foreign DNA [82].
3. Baculoviruses as bioinsecticides
3.1. Introduction
The basis of modern baculovirology was stimulated by the potential utility of baculoviruses
to control insect pests [34]. Baculoviruses are highly infectious and selective pathogens (their
host range is usually limited to one species), are very safe to people and wildlife and long term
crop protection can be established [35]. Despite these advantageous features, the application
of baculovirus as bioinsecticides has not still matched their potential. Although the use of
baculovirus bioinsecticides was hampered by their slow speed of action when compared with
fast‐killing chemical insecticides, they gained increasing acceptance as they were considered
for long term protection of crops, in the framework of integrated pest management.
Up to date, the most successful project was implemented in Brazil where over two million
hectares of soybean were controlled by baculovirus AgMNPV [36, 37]. However, it is important
to notice that a series of factors contributed to the success of AgMNPV as bioinsecticide. First,
AgMNPV is highly pathogenic and only one application is sufficient to control the pest over
the production cycle. In second place, Anticarsia gemmatalis was the most important plague in
soybean crops in Brazil, and other plagues did not cause significant economic damage. Finally,
the application of AgMNPV was promoted by Brazilian state and the integrated pest man‐
agement governmental programs facilitated the public acceptance of alternatives to chemical
insecticides. Despite this favorable unique context, the success of Brazilian project revitalized
the interest in baculovirus as bioinsecticides and many countries and private companies begun
to develop new programs of baculovirus control and the search of novel baculoviruses.
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3.2. Genetic improvement of baculovirus insecticides
In the search of increasing the commercial fitness of baculovirus as bioinsecticides, strategies
to improve the baculovirus pesticide parameters by means of genetic engineering were
developed.
Slow action of baculoviruses often limits its practical application and many strategies aimed
to improving the timing of the pest killing or paralyzation by baculovirus. The first strategies
were based on the interference of host physiology with insect hormones. When a diuretic
hormone gene was introduced into B. mori baculovirus genome, recombinant BmNPV killed
larvae about 20% faster than wild type virus [38]. The expression of this hormone by baculo‐
virus causes the infected larvae to rapidly lose water.
Another strategy was based upon the control of juvenile hormone. In lepidoptera, this
hormone controls the onset of metamorphosis at the final molt. The expression of juvenile
hormone esterase decreases the concentration of the hormone [39, 40]. A reduction in the levels
of juvenile hormone (JH) early in the last larval instar has been shown to initiate metamor‐
phosis and lead to a cessation of feeding behavior. If this juvenile hormone esterase (JHE) is
inhibited, the concentration of JH remains high enough to keep the larva in the feeding stage,
resulting in giant insects. Another approach used consists in the deletion of the virus‐encoded
ecdysteroid glucosyltransferase gene [41]. The product of the egt gene normally prevents larval
molting during infection increasing feeding activity of infected larvae. The EGT enzyme
inactivates hormone ecdysone by transferring sugar molecules. The inactivation of this
hormone results in an increased food consumption, allowing the virus to maximize the viral
progeny. The infection with an egt defective recombinant AcMNPV resulted in a 30% faster
killing of larvae and significant reduction in food consumption.
The degree of improvement that can be achieved by gene deletion alone appears limited. For
this reason, several research lines have focused on the use of gene insertion technology in order
to achieve more substantial improvement in the performance of viral insecticides.
Among the strategies that have been explored to date, the insertion of insect‐specific toxins is
the most promising one for development of commercially viable baculovirus insecticides [42].
In nature, insect predators and parasites use venoms to immobilize their prey. Although
arthropod venoms are composed of a mixture of toxins that may have activity against
organisms other than insects, it is possible to isolate genes that target insects with high
specificity.
Although the first experiments using an insect‐specific toxin of the scorpion Buthus eupeus [42]
did not show an improvement in the speed of action of the recombinant baculovirus, the use
of other scorpion toxin genes resulted in significant enhancement of virus insecticidal per‐
formance. One of the most promising insect‐specific toxins used for the generation of recombi‐
nant baculovirus is the product of the gene AaIT of the scorpion Androctonus australis. The
product of this gene is a small peptide (70 amino acids) that interacts with voltage‐ dependent
sodium channels causing rapid paralysis in insects. Moreover, AaIT has no activity on
vertebrate nervous tissue and is nontoxic to mice. When AaIT toxin was introduced into
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AcMNPV, the speed of kill increased by about 40% and the feeding damage was reduced by
about 60% [43].
Another paralytic toxin that holds promise is the TxP‐I toxin, a component of the venom of the
predatory straw itch mite Pyemotes tritici [44,45]. The mechanism of action this toxin has not been
studied in depth, although it is related to voltage‐dependent calcium channels (VDCC). The
mean time to death of larvae infected with AcMNPV recombinant baculovirus expressing TxP‐
I under the control of p10 very late promoter was reduced by 50‐60% compared to larvae infected
with the wild‐type strain, depending on virus dose and larval instar [46].
The choice of the promoter that controls the transcription of the heterologous toxic gene is very
important. Although polh and p10 very late promotes provides high levels of transcription,
early and late viral promoters or constitutive promoters can result in an earlier accumulation
of the toxin, causing more significant reductions in the speed of paralysis of the larvae. A
chimeric promoter constructed by insertion of the p6.9 promoter downstream of the polh
promoter was found to be more effective than polh promoter alone [47]. Another promoter
tested was the constitutive Drosophila hsp70 heat‐shock protein gene promoter [48]. Despite the
lower levels of toxin accumulation, the results obtained with this promoter were comparable
to those obtained with the p6.9 promoter. The choice of the promoter must be considered from
a biosafety perspective. Evidence indicates that recombinant baculoviruses expressing toxin
genes are not pathogenic to vertebrates, and that the probability of horizontal transfer of the
toxin gene to vertebrates is very low. Moreover, as it was mentioned above, specific arthropod
toxins have no effect on vertebrate neural system. Despite these arguments, it is desirable to
select promoters that are not functional in vertebrates.
3.3. Strategies for modifying host range of baculoviruses
A primary advantage of baculovirus bioinsecticides is their host specificity. In contrast to
chemical insecticides that may harm vertebrates or kill arthropods indiscriminately, baculo‐
viruses target specific populations of insect pests. This feature makes them compatible with
classical biological controls in integrated pest management strategies and makes particularly
useful for controlling insect pests in environmentally sensitive areas. Although bioinsecticides
are attractive from an ecological perspective, their limited host range is undesirable from an
economical point of view. Since many different baculoviruses may be needed to control
complexes of simultaneous insect pests, costs would be excessively high. For this reason, many
researchers have studied the possibility of modifying the baculovirus host range while
maintaining their safety for vertebrates and nontarget arthropods.
3.4. Determinants of virus host range
The host range of any virus is determined by its ability to enter the cells and tissues of a host
organism, replicate and release new infectious virus particles. The virus host range is fre‐
quently determined by the presence of suitable receptors that facilitate virus attachment and
entry into a host cell. This does not appear to be the case for baculoviruses. Baculoviruses are
able to enter nonpermissive insect and even mammalian cells. This indicates that if receptors
are used by baculoviruses, they are common to insect and mammalian cells [49, 50, 51, 52]. In
Current Issues in Molecular Virology - Viral Genetics and Biotechnological Applications92
nonpermissive insect cells, reporter gene expression was observed from early baculovirus
promoters, but expression from very late baculovirus promoters was limited. Expression from
late baculovirus promoters varied among nonpermissive insect cell lines. As mentioned before,
it was established that the transcription from late baculovirus promoters requires the viral
DNA replication [53]. These findings indicate that in nonpermissive insect cells viral DNA is
delivered to the nucleus, the site of baculovirus replication, although replication is restricted
in a cell specific manner. For this reason, the viral genes that determine the host range are likely
to be related with the process of DNA replication.
One of the first steps forward in baculovirus host range alteration was the generation of a
recombinant AcMNPV capable of replicate in nonpermissive B. mori cells and larvae. This was
achieved by replacing the endogenous p143 gene, which encodes an essential protein with
homology to DNA helicases by a hybrid p143 gene [54]. The hybrid p143 gene resulted from
the homologous recombination between AcMNPV and BmNPV p143 genes, and differed from
AcMNPV p143 only in four amino acids. How these changes in p143 affected AcMNPV host
range is still not well understood. Infection of B. mori BmN cells by wild type AcMNPV induces
protein synthesis arrest [55]. This suggests that AcMNPV p143 or perturbations in the cell
caused by AcMNPV p143 or its activity may induce a cellular response. This example dem‐
onstrates that baculovirus host range can be manipulated through genetic engineering.
However, it is important to notice that BmNPV and AcMNPV are closely related baculoviruses
showing on average ORF amino acid sequence identities of about 93%. Although deletion of
a gene critical for replication in one host can reduce the virus host range, in many cases, the
insertion or modification of a single gene will not be sufficient to expand host range. The
expanded AcMNPV host range resulting from p143 recombination with BmNPV is probably
a singular case. Functional complementation studies have conducted to the identification of
other viral elements that may result in host‐ specific interaction. Those elements include the
homologous regions (hrs). Hrs consist of repeated units of about 70 base pairs with an imperfect
30 base pairs palindrome near their center, and have been implicated both as transcriptional
enhancers and origins of DNA replication for a number of baculoviruses. It was demonstrated
that hrs interact with host and viral factors in a species‐specific way. In an interesting work
baculoviruses were analyzed by bioinformatics in the search of genes subject to positive
selection pressure (when the rate of nonsynonymous substitutions per potential nonsynony‐
mous site in a gene is greater than the rate of synonymous substitutions per potential synon‐
ymous site, the gene is said to be undergoing positive selection). Since most genes appear to
be subject to negative selection most of the time, this method can be used to identify viral genes
involved in adapting to new or current hosts [56].
Another relevant topic to be addressed in the development of baculovirus recombinants with
expanded host range is the selection of appropriate promoters for the expression of heterolo‐
gous genes. If selected candidate genes for expansion of the host range are to be incorporated
in the baculovirus genome under the control of their own promoters, it is necessary to evaluate
the functionality of these promoters in this context.
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4. Mammalian cells transduction and BacMam systems
4.1. Introduction
Initial interest in baculoviruses as gene delivery vectors for mammalian cells was driven by
their good biosafety profile [84]. Compared to other human‐derived viral gene delivery
vectors, the safety requirements for handling baculoviruses are relatively low. Baculoviruses
are so exceptionally adapted to their natural hosts that they pose no threat to vertebrate
organisms. They are unable to replicate in mammalian cells, can be manipulated in laboratories
at BSL1/2 levels and can be easily inactivated [85]. Moreover, insect larvae in the wild are
infected via the gut by occluded baculoviruses and polyhedrin‐deleted recombinant virus used
to transduce mammalian cells does not efficiently infect larvae. The viruses are unstable
outside of the laboratory, so they are environmentally contained as well.
Baculovirus entry into mammalian cells was suggested to depend on electrostatic interactions,
heparin sulfate and phospholipids, but the exact cell surface molecules for baculovirus docking
remained unknown [86]. It was also proposed that clathrin‐mediated endocytosis and
macropinocytosis play roles in baculovirus entry [87, 88]. Contradictorily, a recent study [89]
discovered that (1) baculovirus entered cells into vesicles devoid of clathrin; (2) macropino‐
cytosis‐related regulators imparted no significant effects on virus transduction and (3) the
internalization and nuclear uptake were affected by the regulators of clathrin‐independent
entry. These data unveiled a baculovirus entry pathway independent of clathrin‐mediated
endocytosis and macropinocytosis and suggested that phagocytosis might play a role, which
echoed the observations reported previously [90]. Moreover, other recent studies reported that
baculovirus transduction related to direct fusion pathway induced by a short pH trigger [91].
Nevertheless, one consensus is that baculovirus envelope protein gp64 is pivotal for entry
because blocking gp64 can abrogate the baculovirus ability to transduce mammalian cells and
activate dendritic cells [92]. Very recently, it has been demonstrated that 6‐O‐ and N‐sulfated
syndecan‐1 promotes baculovirus binding and entry into mammalian cells. [93].
Numerous cell lines have been transduced [94], including primary cells in vitro and human
livers ex vivo and the capability of baculovirus as a gene therapy vector has been studied. More
recent studies have described the use of AcMNPV vectors in the form of BVs for in vivo
targeting of different organs including brain and liver [95], and stem cells for tissue engineering
[96].
The term BacMam refers to baculoviruses in which a mammalian promoter is used to drive
heterologous gene expression in mammalian cells following viral transduction (Figure 5). Since
the viral genome can stably accommodate an insert sequence of at least 40 kb, BacMams are
particularly suitable for expression of multimeric complexes. Unless a selection force is
applied, gene expression in transduced cells is transient and can usually last for up to 4 days.
However, the expression can even be prolonged to 16 days. For viruses carrying a selectable
marker, stable cell lines can also be established upon selection [97].
BacMams have been used as delivery vehicles to mammalian cells for many polypeptide genes,
including secreted [98] and transmembrane proteins [99, 100, 101]. When high MOIs are used,
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transduction efficiencies near 100% can be reached. With this high transduction efficiency and
flexibility, the technology easily enables coexpression of several genes with multiple baculo‐
viruses and modulation of expression level by dosing and timing. This flexibility is especially
relevant in studies of multimeric complex functional proteins and also in assays of processes
where mix‐and‐match coexpression experiments with a number of cofactors and interacting
partners are necessary.
4.2. Available vectors for BacMam development
The vectors used for the development of BacMams are derivatives from AcMNPV transfer
vectors. The most widely used system for the generations of BacMam are based on the Bac‐to‐
Bac system (InvitrogenTM) for baculovirus generation. With this system the recombinant
baculoviral genome is constructed in E. coli, via a transfer vector. The gene of interest is first
subcloned into a BacMam transfer vector, which is then transformed into a special E. coli strain
DH10Bac to generate the recombinant viral DNA. The viral DNA is then used to transfect
insect cells in order to generate the recombinant virus. The entire process is simple and easy
to perform, allowing generation of multiple viruses simultaneously. With the procedure,
recombinant BacMams can be generated in less than 2 weeks. The Bac‐to‐Bac system [102] uses
Transfer plasmid containig 
          target genes
Recombinant baculovirus
Infected insect cells
Purified budded virus
Transduced animal
Transduced mammalian cells
Expressed multimeric complex
Figure 5. Production and application of BacMam viruses. Target gene sequences cloned into a transfer plasmid con‐
taining a mammalian cell‐active expression cassette are transferred to baculovirus DNA via recombination. The viral
DNA is transfected into insect cells where virus production occurs. Budded virus are clarified from the insect cell cul‐
ture medium. The stock virus is used to transduce mammalian cells and expression of the recombinant protein(s) is
usually validated 24–48 h later. The effects of the expression can be tested with this transient assay. BacMam vectors
can be also used to transduce mammalian organisms.
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the Tn7‐mediated site‐specific transposition reaction to direct integration of expression
cassettes contained in the transfer vector into a baculovirus backbone vector (bacmid) preex‐
isting in the E. coli DH10Bac strain. In this case, the bacmid is a mini‐F replicon with the
baculovirus genome and has a kanamycin resistance marker. In addition, the E. coli strain
contains a helper plasmid that expresses the Tn7 transposase gene. The system was designed
in such a way that the recombinant Tn7 transposon from the transfer vector will be integrated
into a mini‐attTn7 in the lacZα gene fragment contained within the recombinant viral genome,
causing inactivation of the α‐complementation of lacZ. The desired recombinant transformants
will be resistant to tetracycline, kanamycin, and gentamicin and can be easily distinguished
from nonrecombinants by blue/white selection on X‐gal plates.
The BacMam transfer vectors described here are derivatives of pFastBac1 of the Bac‐to‐Bac
system (InvitrogenTM). Originally, the AcMNPV polh promoter of pFastBac1 was deleted for
the introduction of cassettes containing a mammalian promoter. Later, the CMV immediate
early promoter was inserted to allow expression of the cloned cDNA sequences in mammalian
cells. The vector pFastBacMam‐1, in addition, contains a neomycin resistance gene driven by
the SV40 promoter. The neomycin resistance marker allows selection of stable cell lines
following BacMam transduction. Using this vector a new version was constructed (pFast‐
Backmam‐NA) to accommodate ORFs cloned in GatewayTM vectors (Invitrogen).
4.3 Strategies to improve baculovirus transduction
4.3.1. Surface display via gp64 fusion or expression of heterologous protein
Heterologous peptides can be inserted between the signal peptide and the mature domain of
the envelope fusion protein GP64, and this feature has been exploited for surface display of
peptides to improve the virus transduction [103, 104], for ligand‐directed targeting if an
appropriate ligand is chosen [105, 106]. When a short peptide motif from gp350/220 of Epstein–
Barr virus (EBV, which naturally infects B cells) was displayed as GP64 fusion peptide on the
baculovirus envelope [107], the efficiency of transduction to B lymphocytes was increased.
Another paradigm is the display of the immunoglobulin Fc region on the baculovirus surface
[108]. Fc receptors (FcRs) are membrane proteins that bind to the Fc region of antibody and
mediate the phagocytosis and antigen presentation. The Fc display allows for specific bacu‐
lovirus targeting to cell lines and antigen presenting cells (APCs) expressing FcRs, hence
augmenting the vaccine effect. The display system also allows for the surface presentation of
functional membrane proteins to simplify subsequent isolation.
Aside from the gp64‐aided display, expression of vesicular stomatitis virus G protein (VSVG)
[109], influenza virus neuraminidase [110], Spodoptera exigua multiple nucleopolyhedrovirus
F protein, single chain antibody fragments and human endogenous retrovirus envelope
protein [111] in insect cells also leads to incorporation of the protein into baculovirus envelope.
Among these strategies, display of VSVG or heterologous peptide/protein via the VSVG anchor
is the most widely adopted and can tremendously enhance baculovirus transduction in vitro
and in vivo.
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Serum complement proteins (e.g. C5b‐9) inactivate baculovirus, hence constituting a major
hurdle in the in vivo use of baculovirus. The inactivation problem has been circumvented by
the use of complement inhibitors [112] or by displaying human DAF (decay accelerating factor)
via gp64 [113]. The DAF‐displaying baculovirus caused lower levels of inflammatory cytokines
IL‐1β, IL‐6, and IL‐12p40 in macrophages and mitigated liver inflammation in mice when
compared with the control virus. These results demonstrate that DAF display offers protection
to the baculoviral vector against complement inactivation and attenuates complement‐
mediated inflammation injury.
4.3.2. Surface modification via capsid display, chemical coupling or electrostatic interactions
Other than the display on the envelope, heterologous protein has been displayed on the capsid
by fusion with the major capsid protein VP39. The VP39 fusion with enhanced green fluores‐
cent protein (eGFP) neither interferes with the virus assembly nor affects the virus titer, thereby
enabling intracellular baculovirus trafficking and biodistribution monitoring [114]. Similarly,
the ZnO binding peptide has been fused to the N‐terminus of VP39 while retaining the viral
infectivity and conferring the ability to bind nanosized ZnO powders [115]. Besides, by fusing
the protein transduction domain (PTD) of human immunodeficiency virus (HIV) TAT protein
(a protein responsible for nuclear import of HIV genome) with VP39, the engineered baculo‐
virus results in improved transduction of various mammalian cells
Baculovirus can also be chemically conjugated with compounds such as polyethylene glycol
(PEG) alone and folate [116] to improve the transduction of folate receptor‐positive KB cells.
Additionally, baculoviral vectors have been coated with positively charged polyethylenimine
(25 kDa) through electrostatic interactions. The modification imparts baculoviral vectors
resistance to human and rat serum‐mediated inactivation in vitro and elevates in vivo
transduction in the liver and spleen after tail vein injection into mice.
5. Baculovirus display strategies
5.1. Introduction
Recently, a novel molecular biology tool was established by the development of baculovirus
surface display [117‐123], using different strategies for presentation of foreign peptides and
proteins on the surface of budded virions. This eukaryotic display system enables presentation
of large complex proteins on the surface of baculovirus particles and has thereby become a
versatile system in molecular biology.
The baculovirus system offers great potential as an eukaryotic surface display system, since
the post‐translational modification of the recombinant proteins is efficient and high transfec‐
tion rates can be reached. These features are important for the generation of efficient surface
display libraries. The principal applications of such strategies are ligand screening of surface
expression libraries, for example epitope mapping, antigen display for induction of specific
antibodies and presentation of proteins that increase binding to mammalian host cells.
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Moreover, display strategies play an important role, as they may be used to enhance the
efficiency and specificity of viral binding and entry to mammalian cells. In addition, baculo‐
virus surface display vectors have been engineered to contain mammalian promoter elements
designed for gene delivery both in vitro and in vivo. Moreover, baculovirus capsid display has
recently been developed; this holds promise for intracellular targeting of the viral capsid and
subsequent cytosolic delivery of desired protein moieties. Finally, the viruses can accommo‐
date large insertions of foreign DNA and replicate only in insect cells. Together, these are
attributes that are very likely to make them important tools in functional genomics and
proteomics.
Display of foreign proteins or peptides on the surface of various virus particles has been
valuable in a number of areas within life sciences, ranging from basic research such as protein
structure–function studies to diagnostics and gene therapy. One of the most successful
examples of display technology is the isolation of antibodies from large combinatorial libraries
displayed on the surface of the bacteriophages [124]. The versatile principle of phage display
is based on the direct physical linkage between genotype and phenotype. This linkage enables
the selection of basically any protein with the desired characteristics, such as increased binding
affinity or improved catalytic properties from a suitable display library [125]. Phage display
comprises some severe limitations imposed by expression in the bacterial host, however, for
example when large complex eukaryotic proteins that require glycosylation or particular
protein folding are under study.
Over the past few years, the ability to present large complex glycoproteins on the surface of
AcMNPV, has been developed into a versatile system in molecular biology. Expression of
proteins or peptides on the baculoviral surface, or more recently also on the viral capsid,
without compromising replication in insect cells, has shown to be useful for important
applications, both in vivo and in vitro. The major envelope glycoprotein of AcMNPV is
generally known as gp64. The corresponding gene encodes a type I integral membrane
glycoprotein with an amino‐terminal signal sequence and a carboxy‐proximal transmembrane
domain. The GP64 protein occurs on the viral particle as a disulphide‐linked oligomer, most
likely a trimer, and is responsible for viral cell entry mediated by acid‐triggered membrane
fusion. Structural studies on the GP64 protein have identified separate domains responsible
for oligomer formation and membrane fusion. These structural characteristics of gp64 make it
a good candidate as a presentation platform for the development of a eukaryotic‐based viral
surface display system. Modification of viral surface structures by display techniques has
enabled the use of baculovirus for enhanced targeting to mammalian cells in vitro. Based on
the fact that surface display may interfere with baculovirus infectivity, and that molecules
which are displayed on the baculovirus envelope end up in the lysosomes of the mammalian
cell and subsequent acid‐induced fusion of the viral envelope in the endosomes, an approach
for display of foreign protein moieties on the capsid of AcMNPV was recently developed. This
system allows for presentation of desired proteins as fusions with the baculovirus major capsid
protein VP39. By contrast, molecules displayed on the baculovirus capsid should escape
endosomes and thereby follow the capsid through the cytoplasm into the nucleus of trans‐
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duced mammalian cells. Ideally, capsid display should thus enable transfer of functional
molecules into the cytoplasm and/or the nucleus of the target cells.
5.2. Baculoviral display cloning
In the first constructions used to display peptides on the surface of the budded virions the
foreign open reading frames were fused to the complete GP64 coding sequence, with the
parental baculovirus retaining a wild type GP64 copy [126]. The foreign genes were cloned
between the gp64 signal peptide and the mature gp64 peptide. The mechanism of incorpora‐
tion into the viral particle probably involves the oligomerisation of the fusion construct with
wild‐type GP64. Until now, only small peptides have been inserted into the protein gp64 [127,
128]. When entire proteins were inserted the virus budding efficiency decreased drastically,
and titres similar to those of gp64‐deletion mutants were obtained [129]. By comparison of
different positions within the gp64 sequence using specific antibody epitopes, it was found
that the surface probability of the inserted peptide strongly depends on the position, structural
framework and the adjacent amino acids [128]. Incorporation of the fusion protein onto the
viral surface usually represents only a small proportion of the total fusion protein and the
levels of incorporation into the budded virus are variable and cannot be predicted. The position
not only affects the viral titres obtained, but also influences the presentation of the epitope. In
addition to the oligomerization domain and fusion domain, the N‐terminal part of the protein
also contains essential structural or sequential motifs that are more sensitive to changes than
the rest of the protein.
Different promoters for the GP64 fusion protein have been evaluated to increase incorporation
rates and presentation of the displayed peptide [130]. It was noticed that the use of early
promoters resulted in more complete post‐translational processing of glycoproteins; but the
level of fusion protein detected on the surface of cells and budded virus particles was signif‐
icantly enhanced when strong, very late polyhedrin promoter was used. High concentrations
of the target protein are required on the cell surface in order to reach a signal‐to‐noise ratio
that allows cell sorting to be performed by fluorescence‐activated cell sorting, which, at the
moment, is the only practical technique for selecting specific clones from baculovirus surface
display libraries.
As an alternative to using either the entire GP64 or portions of GP64 protein as the scaffold for
protein presentation, the coat protein of a different virus, vesicular stomatitis virus (VSV), or
its membrane anchor domain, has also been evaluated. It was shown that by using this strategy,
incorporation eGFP was extremely high [131]. The avidity of the display virus increased
significantly, without putting a direct limit on the size of the target gene. In the latter cases,
wild‐type gp64 was still expressed in order to maintain efficient infectivity.
6. Conclusions and perspectives
The study of baculoviruses is a traditional field in virology. In particular, genetic engineering
of AcMNPV emerged in the 1980s, and several systems for various purposes have been
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developed. However, although genetic engineering of baculoviruses seems to be a thoroughly
explored area, much work is still required to fully exploit the advantages of the system.
Vectors and cells with many advantageous characteristics have been developed; yet, it would
be tantalizing to assemble all these features in a single system. As mentioned before, the
addition of an IRES to the transfer vector to couple the recombinant ORF to an essential BV
ORF enhanced the genetic stability of the recombinant virus providing sustained recombinant
protein expression. However, this feature is still not commercially available and is not
compatible with many commercial systems. Other alternatives that have been explored and
may be assembled in new generation systems include: selection by rescue of a lethal gene
deletion, deletion of baculovirus chitinase and cathepsin, expression of chaperones and other
folding proteins and expression of mammalian glycosylation pathway proteins.
The use of transgenic cell lines for expression of recombinant proteins is a convenient alter‐
native to baculovirus infection, since the protein is not expressed in an infection context.
Selection systems for the generation of transgenic insect cell lines may be optimized. Systems
based on site‐specific recombination would increase the rate of transgenic cell generation, thus
simplifying clonal cell isolation. Negative selection systems should be explored as well.
Additionally, the development of inducible expression systems would be very convenient,
since they are convenient for expression of proteins that affect cell physiology.
The improvement of baculovirus bioinsecticides by means of genetic engineering is a chal‐
lenging subject. Genetic stability of recombinant baculovirus is an issue, and it is addressed
by strategies such as the addition of an IRES (as mentioned before) and by deleting small
regions with high recombination rates. Many genes from various sources are being tested for
their ability to increase baculovirus biopesticidal propierties, although small RNA‐mediated
silencing will probably emerge as an important alternative to foreign gene expression ap‐
proach. Host range modification is even more challenging. To address this question a system‐
atic study could start by replacing each of the baculovirus genes with related baculovirus
homologs in search of functional complementation. Other various approaches may be
envisaged. Also, bioinformatics studies in search of genes subjected to positive pressure are
valuable to provide candidates of host‐specific interaction genes. These bioinformatics studies
should be updated with the recently sequenced baculovirus genomes. The use of baculovirus
to transduce mammalian cell lines and mammalian organism bring baculovirus in the gene
therapy and vaccine fields. One of the most challenging objectives in this area is the program‐
ming of viral particles to target specific tissues or cell types. In this direction, the replacement
of the baculovirus fusion protein by other fusion proteins have shown to modify baculovirus
BV tropism, and the development of targeted baculovirus is crucial for exploiting their
potential as gene therapy vectors.
From this overview of the field, it is clear that there is room for many strategies and approaches
to improve the various applications of genetically engineered baculoviruses.
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